The pet diabetes care devices market comprises devices that help pets suffering from diabetes to control blood glucose levels. This includes blood glucose monitors which help track fluctuating blood glucose levels. Insulin delivery devices such as insulin pens, syringes, and pumps are also included. These devices allow for precise and convenient insulin delivery for diabetic pets. Adoption of advanced monitoring and insulin delivery devices provides pet owners a way to efficiently manage their pet’s diabetes at home.
The global pet diabetes care devices market is estimated to be valued at US$ 2.42 Bn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the pet diabetes care devices market are Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., and i-SENS, Inc. These key players are focusing on launching innovative products and expanding their global footprint which is expected to drive the market growth.
The growing prevalence of diabetes among pets and increasing pet ownership are major factors fueling the Pet Diabetes Care Devices Market Demand. According to estimates, over 1 million dogs and cats in the U.S. suffer from diabetes. This rising caseload is prompting pet owners to adopt modern treatment options for managing their pets’ diabetes.
The global pet diabetes care devices market is also witnessing strong growth owing to increasing awareness about pet health globally. Leading manufacturers are expanding their operations across international markets to tap the growing demand from pet owners worldwide. Asia Pacific region in particular presents lucrative opportunities for market players due to rising pet care expenditures in countries like India and China.
Market Drivers
The growing elderly pet population is a major driver boosting the adoption of pet diabetes care devices. Elderly pets above 7 years have higher risk of developing diabetes due to age-related pancreatic cell damage. Since pets are living longer due to enhanced veterinary care, demand for diabetes management devices is on the rise. Furthermore, increasing obesity among pets also drives diabetes cases which supports the need for technologically advanced glucose monitors and insulin pens & pumps in pet diabetes management.
Get more insights on Pet Diabetes Care Devices Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian